Talazoparib,Sacituzumab
pfizer,gilead sciences
['tnbc']
#esmo22 #adc combinations for #tnbc not to be missed! early compelling data: staggered w/ io (rather than concurrent) very compelling efficacy &amp; much lower dose limiting toxicities !! via 
Translational Medical Oncologist (Biomarkers, Toxicities, Health Outcomes, Clinico-Genomic Big Data) @OncoAlert. Motto: "Let's make a difference". Views mine.